FERRARO, ANGELO
 Distribuzione geografica
Continente #
NA - Nord America 253
EU - Europa 83
AS - Asia 46
Totale 382
Nazione #
US - Stati Uniti d'America 251
CN - Cina 22
SG - Singapore 20
UA - Ucraina 20
IE - Irlanda 18
FI - Finlandia 10
SE - Svezia 9
IT - Italia 8
NL - Olanda 8
DE - Germania 7
VN - Vietnam 4
GB - Regno Unito 3
CA - Canada 2
Totale 382
Città #
Chandler 57
Jacksonville 24
Houston 20
Woodbridge 20
Ashburn 19
Singapore 12
Beijing 10
Princeton 10
Amsterdam 8
Millbury 6
Los Angeles 5
Santa Clara 5
Boston 4
Dong Ket 4
Dublin 4
Jiaxing 4
Nanjing 4
Wilmington 3
Arienzo 2
Des Moines 2
Bari 1
Boardman 1
Changsha 1
Clifton 1
Dallas 1
Kronberg 1
Marano Di Napoli 1
Nanchang 1
Napoli 1
New York 1
Nocera Inferiore 1
Ottawa 1
Seattle 1
Shenyang 1
Simi Valley 1
Tianjin 1
Toronto 1
Washington 1
Totale 241
Nome #
MicroRNAs (miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycle. 53
UbcH10 expression may be a useful tool in the prognosis of ovarian carcinomas. 51
UbcH10 is overexpressed in malignant breast carcinomas. 45
The cl2/dro1/ccdc80 null mice develop thyroid and ovarian neoplasias 44
FRA-1 protein overexpression is a feature of hyperplastic and neoplastic breast disorders. 41
The loss of the CBX7 gene expression represents an adverse prognostic marker for survival of colon carcinoma patients. 41
CDH-16 gene expression in thyroid cell differentiation and transformation. 35
UbcH10 overexpression is less pronounced in older colorectal cancer patients 34
HMGA2 mRNA expression correlates with the malignant phenotype in human thyroid neoplasias. 29
HAND1 gene expression is negatively regulated by the High Mobility Group A1 proteins and is drastically reduced in human thyroid carcinomas. 27
Totale 400
Categoria #
all - tutte 1.690
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.690


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202027 0 0 4 0 4 0 0 0 0 6 7 6
2020/202147 0 4 7 4 5 7 4 0 5 1 6 4
2021/202266 1 0 0 0 0 1 0 3 14 6 26 15
2022/2023102 10 6 4 12 16 14 0 12 14 8 5 1
2023/202453 1 8 4 4 2 7 0 9 1 5 8 4
2024/202520 14 6 0 0 0 0 0 0 0 0 0 0
Totale 400